AVENALI, MICOL
 Distribuzione geografica
Continente #
NA - Nord America 607
EU - Europa 376
AS - Asia 143
OC - Oceania 2
AF - Africa 1
Totale 1.129
Nazione #
US - Stati Uniti d'America 603
IE - Irlanda 225
CN - Cina 135
IT - Italia 61
FI - Finlandia 35
DE - Germania 26
NL - Olanda 7
BE - Belgio 5
GB - Regno Unito 5
IN - India 5
CA - Canada 4
FR - Francia 3
SE - Svezia 3
AU - Australia 2
RU - Federazione Russa 2
DK - Danimarca 1
ES - Italia 1
IR - Iran 1
LV - Lettonia 1
MY - Malesia 1
RO - Romania 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 1.129
Città #
Dublin 215
Chandler 204
Ashburn 45
Helsinki 32
Princeton 31
Lawrence 29
Medford 27
Beijing 25
Nanjing 25
Wilmington 25
Shanghai 22
Hebei 14
Nanchang 13
New York 12
Fairfield 9
Milan 9
Seattle 9
Hangzhou 8
Amsterdam 7
Ann Arbor 7
Menlo Park 7
Jacksonville 6
Norwalk 6
Rome 6
Shenyang 6
Brussels 5
Changsha 5
Falls Church 5
Los Angeles 5
Pune 5
Cagliari 4
Messina 4
Toronto 4
Washington 4
Ningbo 3
Pavia 3
Pontoglio 3
Tianjin 3
Borås 2
Canberra 2
Como 2
Dearborn 2
Falkenstein 2
Frankfurt am Main 2
Houston 2
Jiaxing 2
Osio Sotto 2
Paris 2
Redwood City 2
Sittingbourne 2
Treviso 2
Austin 1
Berlin 1
Böblingen 1
Cambridge 1
Centurion 1
Cologne 1
Esslingen am Neckar 1
London 1
Madrid 1
Magenta 1
Rho 1
Rognano 1
Saint Paul 1
Shijiazhuang 1
St Petersburg 1
Turi 1
Vancouver 1
Woodbridge 1
Totale 896
Nome #
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 55
Consensus on the treatment of dysphagia in Parkinson's disease 53
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 51
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 49
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 49
Time for a consensus conference on pain in neurorehabilitation 49
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 47
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism 46
CLINICAL AND BIOCHEMICAL SIGNATURES OF GBA-RELATED PARKINSON DISEASE 45
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 44
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 42
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 42
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset 41
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 40
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 38
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 33
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 32
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 31
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: A 6-year longitudinal study 31
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations 31
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 30
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 29
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 28
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 27
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 25
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 24
Reply to: “Increased alpha-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations” 24
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 21
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 20
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial 20
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease 19
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 18
A narrative review on the role and main findings of the Videofluoroscopic Study of Swallowing in Parkison's disease 15
Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study 13
Parkinson disease following COVID-19: Report of six cases 8
Pain in focal dystonias - A focused review to address an important component of the disease 2
Totale 1.172
Categoria #
all - tutte 5.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 32 46 0 2 1 0 0 2 10 7 10 0
2020/202148 0 1 16 2 3 4 0 11 6 3 1 1
2021/2022172 0 1 0 16 9 12 3 13 9 1 19 89
2022/2023549 54 54 5 67 31 40 1 22 251 3 15 6
2023/2024260 37 47 8 22 9 69 29 24 2 11 2 0
Totale 1.172